Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Aug 30, 2023 10:09am
ATE
It looks like we are part of a team of homeless people, no money to support their titles
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Aug 28, 2023 12:28pm
RE:RE:RE:ATE
For context - this drop was associated with less that $6,000 total stock value. It's meaningless without volume.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Comment by
Pronorvista
on Aug 28, 2023 12:13pm
RE:RE:ATE
0.48 now I really had to start believing it again at 0.60 but now it's total disappointment
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Comment by
Pronorvista
on Aug 28, 2023 11:29am
RE:ATE
0,50
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Aug 28, 2023 11:12am
ATE
Legault probably still on vacation will make him laugh at the annual meeting with a title at
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 27, 2023 11:50am
RE:RE:RE:RE:Concentration
There are a few other opportunities that will play a roll if/when acute has success and they are as follows: 1. an additional group of buyers who try to stay away from NA medicines because of
...more
(162)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Aug 26, 2023 9:41pm
RE:RE:RE:Concentration
Mugs, I'm certainly not arguing the potential could be much bigger but I'm more comfortable using past performance metrics for basic assumptions. A successful p2 for $4B chronic enabled the
...more
(218)
•••
baggerx99
X
View Profile
View Bullboard History
Comment by
baggerx99
on Aug 26, 2023 1:35pm
RE:RE:Concentration
whata 100 mc??? 1B rev with a 10 multiple would be 10B m/c.....$20/sh....extrapolate for extra rev's and chronic factoring explodes the sp upward.....imho
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 26, 2023 10:54am
RE:RE:Concentration
Just remember how conservative the numbers are if acute wins - global industry is $13 BB for post-op and we're looking at 50% of that market. Then take 30% of the remaining $12 BB acute
...more
(162)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Aug 25, 2023 11:17pm
RE:Concentration
Yes, certainly some upside potential moving toward p2 readout but I think management set the cap with the exercise price on those 3.1M extended warrants, which I expect them to extend yet again prior
...more
(6)
•••
TheMadMonk
X
View Profile
View Bullboard History
Comment by
TheMadMonk
on Aug 25, 2023 8:13pm
RE:Looks Like
I sure hope that you are right Dusty! I am picking up 2,000 to 5,000 shares per week and this week in the mid 50's was terrible. Hopefully we can drop back to the mid 40's and stay
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Aug 25, 2023 2:56pm
Looks Like
we are going back to the 40,s no one wants to buy "not even management".
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Aug 24, 2023 12:47pm
Back to 51 pennies
ate is usually up on days like today
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 23, 2023 6:09pm
RE:Concentration
So true MadMonk. Exactly what a few of us have been doing over the past year and a half ... realizing there is no market here and taking advantage of the sellers. Once demand returns - we are
...more
(6)
•••
TheMadMonk
X
View Profile
View Bullboard History
Post by
TheMadMonk
on Aug 23, 2023 5:12pm
Concentration
It is going to be interesting to watch what happens to the stock price of ATE if and when we have positive results from P2 next spring. Over the last two years there has been
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >